Experimental Ebola Vaccine To Enter Phase III Trials In Next Two Months, WHO Says

Reuters: Pivotal Ebola vaccine trials to start this month or next: WHO
“Final-stage trials of experimental Ebola vaccines will begin in January or February in the worst-hit West African countries as scientists and drugmakers race to block the deadly disease, the World Health Organization said on Thursday…” (Nebehay, 1/8).

U.N. News Centre: Ebola: vaccine trials can offer ‘signs of hope’ says U.N. health chief
“The United Nations World Health Organization (WHO) [Thursday] convened in Geneva its second-ever high-level meeting on Ebola vaccines access and financing to review the current status of clinical trials and plans for Phase II and Phase III efficacy trials. … The most advanced candidate Ebola vaccine is scheduled to enter Phase III efficacy clinical trials in West Africa in January/February 2015, and if shown effective — will be available for deployment a few months later…” (1/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.